Dr. Angela Dispenzieri discusses results of trial using Velcade in patients with newly-diagnosed high-risk multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.org, theimf@myeloma.org, 800-452-2873 or 818-487-7455
Link to this comment:
All Comments (0)